Orixone S 1000mg/500mg Injection

By Orixone S

Rx

1 Injection in a Vial

Composition icon

Composition

Ceftriaxone(1000mg) + Sulbactam(500mg)

Manufacturer - Otik Biotec icon

Manufacturer - Otik Biotec

SCO-90 1st Floor, Sector 5, Panchkula, Haryana 134112

Expires on or after icon

Expires on or after

October, 2025

About Orixone S 1000mg/500mg Injection

Orixone S 1000mg/500mg Injection is a combination medicine designed to combat various bacterial infections. It works by targeting and inhibiting the growth of harmful microorganisms, thereby stopping the spread of the infection in the body. This injection is a potent tool in the hands of healthcare professionals and should only be administered under their careful supervision.

It is crucial to adhere to the prescribed schedule and not miss any appointments for receiving the Orixone S 1000mg/500mg Injection. Even if symptoms improve, the full course of treatment should be completed as abruptly stopping the medication may reduce its effectiveness. It's important to be mindful of any potential side effects such as nausea, vomiting, diarrhea, and indigestion. Should any of these side effects worsen, immediate consultation with a doctor is recommended.

In case of experiencing an allergic reaction characterized by symptoms like rashes, itching, swelling, or breathing difficulties, prompt medical attention is necessary. Patients are advised to inform their healthcare provider about any other medications they are taking for other health conditions before starting the treatment. Pregnant or breastfeeding women should consult with their doctor prior to taking Orixone S 1000mg/500mg Injection.

Alcohol consumption should be avoided while on this medication to prevent excessive drowsiness. While Orixone S 1000mg/500mg Injection generally does not impair the ability to drive, individuals feeling sleepy or dizzy after administration should refrain from driving. Adequate rest, a nutritious diet, and ample water intake are recommended for a speedy recovery. Laboratory and diagnostic tests may be required by the doctor to monitor the effects of the medicine on the patient's body.


Benefits

Orixone S 1000mg/500mg Injection offers significant benefits in treating bacterial infections effectively. This powerful injection combines two potent medicines, Ceftriaxone and Sulbactum, working in synergy to combat the bacteria responsible for infections. Ceftriaxone functions by halting the growth of bacteria, while Sulbactam plays a crucial role in reducing resistance and boosting the effectiveness of Ceftriaxone against bacterial strains. By targeting a wide range of bacterial infections including those affecting the ear, sinus, throat, lung, urinary tract, skin, and soft tissues, Orixone S 1000mg/500mg Injection brings relief to patients suffering from diverse conditions. Patients typically experience improvement in their symptoms within a few days of starting the treatment. It is essential to complete the prescribed course of Orixone S 1000mg/500mg Injection even if symptoms improve, ensuring all bacteria are eradicated and reducing the risk of resistance development. Orixone S 1000mg/500mg Injection stands out as a reliable and efficient treatment option for bacterial infections, offering timely and comprehensive relief while safeguarding against antibiotic resistance.


How to use the Orixone S 1000mg/500mg Injection

To use Orixone S 1000mg/500mg Injection, it is important to have a healthcare professional, such as a doctor or nurse, administer it to you. It is not safe to self-administer this medicine, so always rely on trained professionals for the injection. They will provide the correct dosage and ensure it is administered correctly. This injection is given directly into a vein or muscle, as directed by your healthcare provider. Be sure to follow their instructions carefully and do not attempt to inject yourself. Proper administration of this medication is essential for its effectiveness and your safety, so always seek professional help when using Orixone S 1000mg/500mg Injection.


Uses of Orixone S 1000mg/500mg Injection

Orixone S 1000mg/500mg Injection is commonly used to treat bacterial infections in the body. This injection helps to fight off and eliminate harmful bacteria that can cause illnesses. It is often prescribed by healthcare professionals to address a variety of bacterial infections. By targeting the specific bacterial strain causing the infection, Orixone S 1000mg/500mg Injection helps in reducing the severity of symptoms and promoting recovery. It is important to follow the healthcare provider's instructions when using this injection to ensure its effectiveness in combating bacterial infections.


What conditions Orixone S 1000mg/500mg Injection treats?

Orixone S 1000mg/500mg Injection is used to treat bacterial infections. It contains Ceftriaxone and Sulbactam which work together to kill the bacteria causing the infections. This medication can be used for various infections like ear, sinus, throat, lung, urinary tract, skin, and soft tissues. It is important to complete the full course of treatment even if symptoms improve, as stopping abruptly can impact its effectiveness. Monitor for common side effects like nausea, vomiting, and diarrhea, and seek medical help if severe reactions or allergies occur.


Should you consult a doctor?

If you experience any severe side effects such as allergic reactions (like rashes, itching, swelling, or difficulty breathing), it is crucial to seek immediate medical help. Additionally, if common side effects like nausea, vomiting, or diarrhea worsen, consult your doctor promptly.


Inform your healthcare provider if you encounter any concerning symptoms or changes while taking Orixone S 1000mg/500mg Injection. This is particularly important if you notice a significant decrease in white blood cell count, abnormalities in blood platelets, or increased liver enzymes.


If there are any unexpected reactions or if you feel unsure about the effects of the medication, it is advisable to schedule a consultation with your doctor. Remember that completing the prescribed treatment even if you start to feel better is essential for effective recovery.


Side effects of Orixone S 1000mg/500mg Injection

Possible side effects of Orixone S 1000mg/500mg Injection may include changes in blood cell counts such as increased levels of eosinophils or decreased levels of lymphocytes, as well as low blood platelets. Other side effects may manifest as rash, diarrhea, or increased liver enzymes. It is also possible to experience injection site reactions like pain, swelling, or redness. These side effects are generally not alarming and may fade as your body adapts to the medication. However, if these side effects persist or cause concern, it is advisable to consult your doctor.


Safety advice

scroll

liver

When using Orixone S 1000mg/500mg Injection, it is important to be cautious if you have severe liver disease. In such cases, a dose adjustment may be necessary, and it is advisable to consult your doctor. However, for individuals with mild to moderate liver disease, dose adjustment of Orixone S 1000mg/500mg Injection is generally not recommended. It's crucial to consider your liver health when using this medication to ensure its safety and effectiveness.

scroll

kidney

Limited information exists on using Orixone S 1000mg/500mg Injection in patients with kidney disease. Kindly seek advice from your doctor for guidance.

scroll

alcohol

It is safe to consume alcohol with Orixone S 1000mg/500mg Injection with no harmful side effects.

scroll

driving

Orixone S 1000mg/500mg Injection can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these side effects.

scroll

pregnancy

Orixone S 1000mg/500mg Injection is generally considered safe to use during pregnancy based on animal studies showing low risk to the developing baby. Limited human studies are available.

scroll

breastfeeding

Orixone S 1000mg/500mg Injection needs caution while breastfeeding. It's advisable to pause breastfeeding until the mother's treatment is done and the drug is cleared from her system.


Consumption warning before consuming Orixone S 1000mg/500mg Injection

Before consuming Orixone S 1000mg/500mg Injection, it is crucial to follow these important warnings. This medication is designed to combat bacterial infections and should only be administered under the supervision of a healthcare professional. It is essential not to miss any scheduled appointments for taking this medicine as the full treatment course must be completed, even if symptoms improve. Abruptly stopping the treatment may reduce its effectiveness.


Common side effects like nausea, vomiting, and diarrhea may occur. If these worsen, consult your doctor promptly. Any signs of allergic reactions such as rashes, itching, or breathing difficulties require immediate medical attention.


Prior to taking this medicine, inform your doctor about any other medications you are using. Pregnant or breastfeeding women should seek medical advice before using the medication. Avoid alcohol consumption as it may lead to increased drowsiness. While this medicine typically does not hinder driving ability, refrain from driving if feeling drowsy or dizzy. Adequate rest, a healthy diet, and staying hydrated can aid in a faster recovery. Your doctor may request laboratory tests to monitor the medication's effects on your body.


What if you forgot to take Orixone S 1000mg/500mg Injection?

If you forget to take a dose of Orixone S 1000mg/500mg Injection, it is important to consult your doctor. Missing a dose may affect the effectiveness of the medication in treating your condition. Your doctor can provide guidance on whether you should take the missed dose or adjust your dosing schedule. It is essential to follow your doctor's instructions to ensure you are receiving the proper treatment. If you have any concerns about missing a dose or need more information, do not hesitate to reach out to your healthcare provider for assistance.


Related lab tests

Related Lab Tests for monitoring patients receiving Orixone S 1000mg/500mg Injection include Complete Blood Count (CBC) and Peripheral Smear Examination. These tests are important to assess the overall health of the patient during treatment with Orixone S 1000mg/500mg Injection. The Complete Blood Count helps to evaluate the number of different types of blood cells, such as red blood cells, white blood cells, and platelets. Changes in these counts can indicate potential side effects or complications from the medication. The Peripheral Smear Examination involves analyzing a sample of blood under a microscope to look for abnormalities in the blood cells' size, shape, and distribution. This test can provide additional information about the patient's blood health and response to the medication. Regular monitoring of these lab tests can help healthcare providers ensure the safety and effectiveness of treatment with Orixone S 1000mg/500mg Injection.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI INFECTIVES
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

123

Inclusive of all taxes

Content verified by

chevron-right

Dr. Gowri Kulkarni

MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)

Last update on 18-Nov-2024